Open Label Continuation Study of TRC105 for Patients Who Have Completed a Prior TRC105 Trial

Open-label Study of Topotecan and Pazopanib in Advanced Solid Tumors

NCT00732420 ·Status: COMPLETED ·Phase: PHASE1

A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors

NCT04478279 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

A Phase 1b Trial of ATRC-101 in Adults With Advanced Solid Malignancies

NCT04244552 ·Status: TERMINATED ·Phase: PHASE1

Phase 1-2 Study of ASTX660 in Subjects With Advanced Solid Tumors and Lymphomas

NCT02503423 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

Testing the Addition of an Anti-cancer Drug, Copanlisib, to the Usual Immunotherapy (Nivolumab With or Without Ipilimumab) in Patients With Advanced Solid Cancers That Have Changes in the Following Genes: PIK3CA and PTEN

NCT04317105 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

A Study to Assess the Safety and Tolerability of Adavosertib for Patients With Advanced Solid Tumours

NCT04949425 ·Status: TERMINATED ·Phase: PHASE1

Study to Assess Safety & Tolerability of AZD2281 in Combination With Bevacizumab in Patients With Advanced Solid Tumours

NCT00710268 ·Status: COMPLETED ·Phase: PHASE1

A Single Arm, Multicenter, Phase II Trial of RAD001 as Monotherapy in the Palliative Treatment of Patients With TCC After Failure of Chemotherapy

NCT00714025 ·Status: COMPLETED ·Phase: PHASE2

An Open-Label Dose-Escalation Study to Evaluate XmAb24306 as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors

NCT04250155 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Study of APR-1051 in Patients With Advanced Solid Tumors

NCT06260514 ·Status: RECRUITING ·Phase: PHASE1

AZD2171 + Chemotherapy in Advanced NSCLC, Colorectal Cancer, or Other Cancer Suitable for Treatment With Capecitabine (Non-Small Lung Cancer Patients Closed to Enrollment as 8/9/07)

NCT00107250 ·Status: COMPLETED ·Phase: PHASE1

Study of Troxatyl™ Administered by Continuous Infusion to Subjects With Solid Tumors

NCT00104286 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

An Open-Label, Dose-Escalation/Dose-Expansion Safety Study of INCB059872 in Subjects With Advanced Malignancies

NCT02712905 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Dose Escalation Study of MLN0128 in Combination With Paclitaxel, With/Without Trastuzumab, in Subjects With Advanced Solid Malignancies

NCT01351350 ·Status: COMPLETED ·Phase: PHASE1

A Study of LOR-253 HCl in Patients With Advanced or Metastatic Solid Tumours

NCT01281592 ·Status: COMPLETED ·Phase: PHASE1

A Study of Tor Kinase Inhibitor in Advanced Tumors

NCT00731263 ·Status: COMPLETED ·Phase: PHASE1

Phase 1 Study of ACR-2316 in Specific Advanced Solid Tumors

NCT06667141 ·Status: RECRUITING ·Phase: PHASE1

Safety, Pharmacokinetics and Pharmacodynamics of BEZ235 Plus MEK162 in Selected Advanced Solid Tumor Patients

NCT01337765 ·Status: COMPLETED ·Phase: PHASE1

Study for Patients Who Have Benefited and Tolerated Prior Panitumumab Treatment

NCT00425204 ·Status: COMPLETED ·Phase: PHASE2

A Study Of PF-06647263 In Patients With Advanced Solid Tumors

NCT02078752 ·Status: TERMINATED ·Phase: PHASE1

A Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of TT125-802 in Subjects With Advanced Solid Tumors

NCT06403436 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

A Study of the Safety, Tolerability and Pharmacokinetics of ABBV-368 as a Single Agent and Combination in Subjects With Locally Advanced or Metastatic Solid Tumors

NCT03071757 ·Status: COMPLETED ·Phase: PHASE1

Phase I Study in Patients With Solid Tumours

NCT00496028 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate Maximum Tolerated Dose of Oral CB-03-10 With Dose Expansion Phase, in Advanced Solid Tumors

NCT03863145 ·Status: RECRUITING ·Phase: EARLY_PHASE1

A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid Tumors

NCT02498613 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2